152 related articles for article (PubMed ID: 36287918)
1. In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera.
Charla R; Patil PP; Bhatkande AA; Khode NR; Balaganur V; Hegde HV; Harish DR; Roy S
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287918
[TBL] [Abstract][Full Text] [Related]
2. Anti-Cholera toxin activity of selected polyphenols from
Charla R; Patil PP; Patil VS; Bhandare VV; Karoshi V; Balaganur V; Joshi RK; Harish DR; Roy S
Front Cell Infect Microbiol; 2023; 13():1106293. PubMed ID: 37113136
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1.
Saha PK; Koley H; Nair GB
Infect Immun; 1996 Aug; 64(8):3101-8. PubMed ID: 8757840
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of cholera toxin by Rosaceae family plant extracts.
Komiazyk M; Palczewska M; Sitkiewicz I; Pikula S; Groves P
BMC Complement Altern Med; 2019 Jun; 19(1):140. PubMed ID: 31221152
[TBL] [Abstract][Full Text] [Related]
5. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells.
Chatterjee D; Chaudhuri K
FEBS Lett; 2011 May; 585(9):1357-62. PubMed ID: 21510946
[TBL] [Abstract][Full Text] [Related]
6. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
Yu RK; Usuki S; Itokazu Y; Wu HC
Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
[TBL] [Abstract][Full Text] [Related]
7. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
Saha S; Sanyal SC
Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera.
Das S; Angsantikul P; Le C; Bao D; Miyamoto Y; Gao W; Zhang L; Eckmann L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006266. PubMed ID: 29470490
[TBL] [Abstract][Full Text] [Related]
9. Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo.
Saha P; Das B; Chaudhuri K
Antimicrob Agents Chemother; 2013 Sep; 57(9):4373-80. PubMed ID: 23817372
[TBL] [Abstract][Full Text] [Related]
10. [Influence of plant extracts on the activity of cholera toxin of Vibrio cholerae].
Markina OV; Alekseeva LP; Markin NV; Telesmanich NR
Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):9-13. PubMed ID: 23805645
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cholera toxin and ganglioside G(M1).
Svennerholm L
Adv Exp Med Biol; 1976; 71():191-204. PubMed ID: 937147
[TBL] [Abstract][Full Text] [Related]
12. Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor.
Sarwar S; Ali A; Pal M; Chakrabarti P
J Biol Chem; 2017 Nov; 292(44):18303-18311. PubMed ID: 28882894
[No Abstract] [Full Text] [Related]
13. Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction.
Rivera FP; Medina AM; Bezada S; Valencia R; Bernal M; Meza R; Maves RC; Ochoa TJ
PLoS One; 2013; 8(4):e59253. PubMed ID: 23580005
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring.
Jin D; Luo Y; Zheng M; Li H; Zhang J; Stampfl M; Xu X; Ding G; Zhang Y; Tang YW
J Clin Microbiol; 2013 Dec; 51(12):3968-74. PubMed ID: 24048535
[TBL] [Abstract][Full Text] [Related]
15. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
Blanco LP; DiRita VJ
Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
[TBL] [Abstract][Full Text] [Related]
16. Variation in epitopes of the B subunit of Vibrio cholerae non-O1 and Vibrio mimicus cholera toxins.
Tamplin ML; Jalali R; Ahmed MK; Colwell RR
Can J Microbiol; 1990 Jun; 36(6):409-13. PubMed ID: 1697780
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine.
Holmgren J; Lönnroth I; Månsson J; Svennerholm L
Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2520-4. PubMed ID: 1058471
[TBL] [Abstract][Full Text] [Related]
18. The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition.
Margheri G; D'Agostino R; Trigari S; Sottini S; Del Rosso M
Lipids; 2014 Feb; 49(2):203-6. PubMed ID: 24122042
[TBL] [Abstract][Full Text] [Related]
19. Cholera: pathophysiology and emerging therapeutic targets.
Muanprasat C; Chatsudthipong V
Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
Holmgren J
Infect Immun; 1973 Dec; 8(6):851-9. PubMed ID: 4206342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
